07:00 , May 3, 2010 |  BC Week In Review  |  Clinical News

Alair System regulatory update

FDA approved a PMA from Asthmatx for the Alair bronchial thermoplasty system to treat adults whose severe and persistent asthma is not well-controlled with an inhaled corticosteroid and a long-acting adrenergic receptor beta 2 (ADRB2)...
08:00 , Nov 2, 2009 |  BC Week In Review  |  Clinical News

Alair System regulatory update

FDA's Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee voted 6 to 1 to recommend approval of a PMA from Asthmatx for Alair System to treat severe persistent asthma in adults....
07:00 , Aug 17, 2009 |  BioCentury  |  Product Development

Heating up the airways

Asthmatx Inc. believes its Alair bronchial thermoplasty system will significantly improve quality of life for patients with severe asthma who are not adequately served by drugs. If successful, the treatment would be added on to...
07:00 , May 25, 2009 |  BC Week In Review  |  Clinical News

Alair System: Phase III data

Data from the double-blind, international Phase III AIR2 trial in 297 patients showed that Alair significantly improved the average AQLQ scores at 6-, 9- and 12- months compared with the sham control (80% vs. 64%)....